Elevated Levels of Methylmalonate and Homocysteine in Parkinson’s Disease, Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis

Publisher： Karger

E-ISSN： 1421-9824|29|6|553-559

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.29, Iss.6, 2010-07, pp. : 553-559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Birth Cohort Effects in Neurological Diseases: Amyotrophic Lateral Sclerosis, Parkinson’s Disease and Multiple Sclerosis

By  

Neuroepidemiology, Vol. 38, Iss. 1, 2012-01 ,pp. : 56-63

Karger

Access to resources Recommend Favorite

No Role for Melanoma Treatment in the Association between Melanoma and Amyotrophic Lateral Sclerosis or Parkinson’s Disease

By  

Neuroepidemiology, Vol. 35, Iss. 4, 2010-10 ,pp. : 303-304

Karger

Access to resources Recommend Favorite

Mortality due to Amyotrophic Lateral Sclerosis and Parkinson’s Disease among Melanoma Patients

By  

Neuroepidemiology, Vol. 28, Iss. 1, 2006-12 ,pp. : 16-20

Karger

Access to resources Recommend Favorite

Elevated Plasma Levels of Homocysteine inParkinson’s Disease

By  

European Neurology, Vol. 40, Iss. 4, 1998-11 ,pp. : 225-227

Karger

Access to resources Recommend Favorite

Comparative Gait Analysis in Progressive Supranuclear Palsy and Parkinson's Disease

By  

European Neurology, Vol. 75, Iss. 5-6, 2016-06 ,pp. : 282-289

Karger

Access to resources Recommend Favorite